Keyphrases
Tolfenamic Acid
97%
Specificity Protein 1
59%
Transcription Factor
38%
Alzheimer's Disease
32%
Pancreatic Cancer Cells
28%
Survivin
27%
Small Molecules
24%
Pancreatic Cancer
24%
Curcumin
21%
Prostate Cancer
20%
Anticancer Activity
20%
In Cancer
19%
Colorectal Cancer
18%
Tumor Growth
18%
Cancer Cell Growth
16%
Cell Proliferation
14%
Health Disparities
13%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
13%
Malignancy
13%
Antiproliferative Activity
13%
Risk Factors
13%
Tumorigenesis
13%
Therapeutic Potential
13%
Amyloidogenesis
13%
DNA Binding
13%
Amyloid Precursor Protein
13%
Clinical Trials
12%
Hepatocellular Carcinoma
12%
Diazepam
11%
Reactive Oxygen Species
11%
United States
10%
Chemotherapy
10%
Tumor
9%
C-Met
9%
Cell Viability
8%
Ethanol
8%
Ovarian Cancer
8%
Neuroblastoma Cells
8%
Induced Apoptosis
8%
Cancer Tumor
8%
Cancer Mortality
8%
Breast Cancer
8%
Nanoparticles
8%
Monkey
8%
Hippocampus
8%
Old Age
8%
Cell Tumor
8%
Medulloblastoma
7%
Ewing Sarcoma
7%
Chemopreventive
7%
Pharmacology, Toxicology and Pharmaceutical Science
Tolfenamic Acid
100%
Malignant Neoplasm
80%
Pancreas Cancer
49%
Transcription Factors
37%
Survivin
35%
Transcription Factor Sp1
26%
Curcumin
26%
Cancer Growth
22%
Clinical Trial
21%
Alzheimer's Disease
19%
Neoplasm
19%
Prostate Cancer
19%
Immunotherapy
19%
Disease
18%
Colorectal Carcinoma
18%
Carcinogenesis
18%
Tumor Growth
17%
Chemotherapy
13%
Nanoparticle
13%
Non-Steroidal Anti-Inflammatory Drug
13%
Ovary Cancer
11%
Digestive System Cancer
11%
Colon Carcinoma
11%
Reactive Oxygen Metabolite
10%
Biological Marker
9%
Neuroblastoma
8%
Acetylcholinesterase
8%
Liver Cell Carcinoma
8%
Cell Viability
8%
Vincristine
8%
Ewing Sarcoma
7%
Medulloblastoma
7%
Breast Cancer
7%
Metformin
7%
Diazepam
7%
Chelating Agent
7%
Non Insulin Dependent Diabetes Mellitus
7%
Preclinical Study
7%
Xenobiotic Agent
7%
Liver Cancer
6%
Pancreas Adenocarcinoma
6%
Mithramycin
6%
Esophagus Cancer
6%
Survival Rate
6%
Drug Resistance
6%
Nerve Degeneration
5%
Western Blot
5%
Flow Cytometry
5%
Mouse Model
5%
Bioavailability
5%
Medicine and Dentistry
Malignant Neoplasm
32%
Tolfenamic Acid
18%
Pancreas Cancer
16%
Immunotherapy
16%
Colorectal Carcinoma
13%
Transcription Factor Sp1
13%
Clinical Trial
12%
Disease
12%
Hepatocellular Carcinoma
12%
Cancer Cell
11%
Health Disparity
10%
Biological Marker
9%
Cell Proliferation
9%
Survivin
8%
Personalized Medicine
8%
Chemotherapy
8%
Prostate Cancer
8%
Breast Cancer
8%
Ovarian Cancer
8%
Maturity Onset Diabetes of the Young
7%
Curcumin
7%
Cancer
7%
Liver Cancer
7%
Alzheimer's Disease
6%
Survival Rate
6%
Gastrointestinal Cancer
6%
Neoplasm
6%
Drug Resistance
6%
Programmed Cell Death
5%
Cancer Therapy
5%
Metastatic Carcinoma
5%
Ras Signaling
5%
Gene Mutation
5%
Reactive Oxygen Species
5%
Angiogenesis
5%
Primary Tumor
5%